ADVERTISEMENT
Search

 

Press Releases

 

3

May

2023

Provider Status Alert: Maryland pharmacists can now bill for their services

Author: James Keagy

ANNAPOLIS, MD, and WASHINGTON, DC—The Maryland Pharmacists Association (MPhA), Maryland Pharmacy Coalition (MPC), and American Pharmacists Association (APhA) are proud to announce that Maryland pharmacists will soon have expanded ability to bill for certain health care services.

Comments (0)
Number of views (6441)
Article rating: No rating

27

Apr

2023

APhA selects permanent CEO

Author: James Keagy

(WASHINGTON, DC) Today, the American Pharmacists Association (APhA) announced that Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, has been named the 15th Chief Executive Officer and Executive Vice President of APhA.

Comments (0)
Number of views (8362)
Article rating: No rating

24

Apr

2023

APhA House of Delegates addresses progressive topics facing the profession

(Washington, DC) American Pharmacists Association (APhA) and its House of Delegates, the premier policy-making body for the pharmacy profession, considered and adopted new policies on pressing issues during APhA’s annual meeting on March 24 –27, 2023, in Phoenix. 

Comments (0)
Number of views (1537)
Article rating: No rating

14

Apr

2023

APhA applauds HHS for extending PREP Act authorities for pharmacy personnel

Author: James Keagy

The American Pharmacists Association (APhA) commends the U.S. Department of Health and Human Services (HHS) for announcing that they will ensure that patients can continue to get COVID-19–related care from their pharmacists. APhA is grateful that HHS listened to the concerns of APhA and others in the pharmacy community in expressing a need for HHS to clarify the role of pharmacists and pharmacy teams when the public health emergency expires on May 11, 2023.

Comments (0)
Number of views (7248)
Article rating: No rating

7

Apr

2023

APhA statement related to Texas District Court decision regarding mifepristone

The American Pharmacists Association released the following statement in response to the decision in the Alliance for Hippocratic Medicine v U.S. Food and Drug Administration lawsuit file in the US District Court for the Northern District of Texas, regarding FDA approval of mifepristone. 

Comments (0)
Number of views (5735)
Article rating: No rating
RSS
First2345791011Last
ADVERTISEMENT